Erica Castellini, in Asbury Park, NJ - Acupuncturist

Erica Castellini, is a Acupuncturist based in Asbury Park, New Jersey. Erica Castellini is licensed to practice in New Jersey (license number 25MZ00101500) and her current practice location is 418 Bond St, Asbury Park, New Jersey. She can be reached at her office (for appointments etc.) via phone at (732) 361-3609.

NPI number for Erica Castellini is 1013342047 and her current mailing address is 1209 5th Ave, Asbury Park, New Jersey. She does not participate in medicare program and thus does not accept medicare assignments. Her NPI Number is 1013342047.

Contact Information

	Erica Castellini,
	418 Bond St, Asbury Park, NJ 07712-6908
	(732) 361-3609
	(732) 210-0202

Healthcare Provider's Profile

Full Name	Erica Castellini
Gender	Female
Speciality	Acupuncturist
Location	418 Bond St, Asbury Park, New Jersey
Accepts Medicare Assignments	Does not participate in Medicare Program. She may not accept medicare assignment.

NPI Data:

NPI Number: 1013342047
Provider Enumeration Date: 09/10/2013
Last Update Date: 10/22/2020

Medical Identifiers

Medical identifiers for Erica Castellini such as npi, medicare ID, medicare PIN, medicaid, etc.

Identifier	Type	State	Issuer
1013342047	NPI	-	NPPES

Medical Taxonomies and Licenses

Taxonomy	Type	License (State)	Status
1041C0700X	Social Worker - Clinical	44SC05496800 (New Jersey)	Secondary
171100000X	Acupuncturist	25MZ00101500 (New Jersey)	Primary

Medicare Part D Prescriber Enrollment

Any physician or other eligible professional who prescribes Part D drugs must either enroll in the Medicare program or opt out in order to prescribe drugs to their patients with Part D prescription drug benefit plans. Erica Castellini is NOT enrolled with medicare and thus cannot prescribe medicare part D drugs to patients with medicare part D benefits.

Mailing Address and Practice Location

Mailing Address	Practice Location Address
Erica Castellini, 1209 5th Ave, Asbury Park, NJ 07712-4903 Ph: (732) 219-1900	Erica Castellini, 418 Bond St, Asbury Park, NJ 07712-6908 Ph: (732) 361-3609

News Archive

Clinical results of FlexStent Femoropopliteal Self Expanding Stent System presented

Interim six month clinical results on the use of the FlexStent Femoropopliteal Self Expanding Stent System in the Superficial Femoral Artery were presented today at the VIVA conference by Dr. William Gray of NY Columbia-Presbyterian Hospital.

Cleaver Scientific's VS20 WAVE system provides fully integrated solution for gel electrophoresis

The VS20 WAVE from Cleaver Scientific is a single tank electrophoresis system which provides a fully integrated solution for vertical PAGE, tube gel IEF and electro blotting.

Study evaluates VolitionRx's proprietary Nucleosomics platform in most prevalent cancers

VolitionRx Limited, a life sciences company focused on developing blood-based diagnostic tests for a broad range of cancer types and other conditions, today announced that it has accelerated its large independent prospective study evaluating its proprietary Nucleosomics platform at University Hospital Bonn in Germany.

Novel drug could improve life expectancy and quality for patients with hard-to-treat cancers

The Sheffield researchers founded the spin-out Modulus Oncology with a team of experienced biotech entrepreneurs to fast-track the drug into clinical testing within two years.

Erica Castellini, - in Asbury Park, NJ